Literature DB >> 29393240

Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD.

Roy T M Sprooten1, Kaatje Lenaerts2, Dionne C W Braeken1,3, Ilvy Grimbergen1, Erica P Rutten3, Emiel F M Wouters1,3, Gernot G U Rohde1,4.   

Abstract

BACKGROUND: Disturbances of intestinal integrity, manifested by increased gastro-intestinal (GI) permeability, have been found in chronic obstructive pulmonary disease (COPD) patients during physical activity, often associated with intermittent hypoxic periods. Evidence about extrapulmonary organ disturbances, especially of the GI tract, during hospitalised acute exacerbation of COPD (AE-COPD) with hypoxaemic respiratory failure (RF) is lacking.
OBJECTIVE: The aim was to assess changes in GI permeability in patients with AE-COPD and during recovery 4 weeks later.
METHODS: All patients admitted to our hospital with AE-COPD accompanied by hypoxaemia at admission (PaO2 <8.7 kPa or O2 saturation <93%) were screened between October 2013 and February 2014. Patients with a history of GI or renal disease, chronic heart failure, or use of non-steroidal anti-inflammatory drugs in the 48 h before the test were excluded. GI permeability was assessed by evaluating urinary excretion ratios of the orally ingested sugars lactulose/L-rhamnose (L/R ratio), sucrose/L-rhamnose (Su/R ratio) and sucralose/erythritol (S/E ratio).
RESULTS: Seventeen patients with severe to very severe COPD completed the study. L/R ratio (×103) at admission of AE-COPD was significantly higher than in the recovery condition (40.9 [29.4-49.6] vs. 27.3 [19.5-47.7], p = 0.039), indicating increased small intestinal permeability. There were no significant differences in the individual sugar levels in urine nor in the 0- to 5-h urinary S/E and Su/R ratios between the 2 visits.
CONCLUSION: This is the first study showing increased GI permeability during hospitalised AE-COPD accompanied by hypoxaemic RF. Therefore, GI integrity in COPD patients is an attractive target for future research and for the development of interventions to alleviate the consequences of AE-COPD.
© 2018 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Barrier function; Hospital admission; Hypoxaemia; Lactulose/L-rhamnose ratio; Small intestine

Mesh:

Year:  2018        PMID: 29393240      PMCID: PMC5985742          DOI: 10.1159/000485935

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  54 in total

1.  Gastrointestinal profile of symptomatic athletes at rest and during physical exercise.

Authors:  Michiel A van Nieuwenhoven; Fred Brouns; Robert-Jan M Brummer
Journal:  Eur J Appl Physiol       Date:  2003-11-22       Impact factor: 3.078

2.  Changes in the gastrointestinal mucosa after long-distance running.

Authors:  O Oktedalen; O C Lunde; P K Opstad; L Aabakken; K Kvernebo
Journal:  Scand J Gastroenterol       Date:  1992-04       Impact factor: 2.423

3.  Novel analytical approach to a multi-sugar whole gut permeability assay.

Authors:  Kim van Wijck; Hans M H van Eijk; Wim A Buurman; Cornelis H C Dejong; Kaatje Lenaerts
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-08-10       Impact factor: 3.205

4.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; A Bhowmik; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 6.  Intestinal permeability: an overview.

Authors:  I Bjarnason; A MacPherson; D Hollander
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

7.  Splanchnic oxygen transport, hepatic function and gastrointestinal barrier after normothermic cardiopulmonary bypass.

Authors:  J P Braun; T Schroeder; S Buehner; P Dohmen; M Moshirzadeh; J Grosse; F Streit; A Schlaefke; V W Armstrong; M Oellerich; H Lochs; W Konertz; W J Kox; C Spies
Journal:  Acta Anaesthesiol Scand       Date:  2004-07       Impact factor: 2.105

8.  COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice.

Authors:  Gudmundur Sigthorsson; Robert J Simpson; Matthew Walley; Andrew Anthony; Russell Foster; Christoph Hotz-Behoftsitz; Abbas Palizban; Joaquim Pombo; Jo Watts; Scott G Morham; Ingvar Bjarnason
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

9.  Pitfalls in gastrointestinal permeability measurement in ICU patients.

Authors:  Falco Hietbrink; Marc G H Besselink; Willem Renooij; Luke P H Leenen
Journal:  Intensive Care Med       Date:  2007-07-06       Impact factor: 17.440

10.  Cardiac autonomic function in patients with acute exacerbation of chronic obstructive pulmonary disease with and without ventricular tachycardia.

Authors:  Xingde Wang; Zhaohua Jiang; Bin Chen; Li Zhou; Zhibin Kong; Sheng Zuo; Hua Liu; Shaojun Yin
Journal:  BMC Pulm Med       Date:  2016-08-20       Impact factor: 3.317

View more
  20 in total

1.  Circulating 1,3-Beta-D-Glucan is Associated with Lung Function, Respiratory Symptoms, and Mediators of Matrix Degradation in Chronic Obstructive Pulmonary Disease.

Authors:  Matthew Gorgone; Deepti Singhvi; Seyed Mehdi Nouraie; Malcolm Finkelman; Yonglong Zhang; Jiantao Pu; Divay Chandra; Yingze Zhang; Georgios D Kitsios; Alison Morris; Frank C Sciurba; Jessica Bon
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

Review 2.  Microbiota in health and diseases.

Authors:  Kaijian Hou; Zhuo-Xun Wu; Xuan-Yu Chen; Jing-Quan Wang; Dongya Zhang; Chuanxing Xiao; Dan Zhu; Jagadish B Koya; Liuya Wei; Jilin Li; Zhe-Sheng Chen
Journal:  Signal Transduct Target Ther       Date:  2022-04-23

3.  Intestinal function is impaired in patients with Chronic Obstructive Pulmonary Disease.

Authors:  Sarah K Kirschner; Nicolaas E P Deutz; Renate Jonker; Steven W M Olde Damink; Rajesh I Harrykissoon; Anthony J Zachria; Srinivasan Dasarathy; Mariëlle P K J Engelen
Journal:  Clin Nutr       Date:  2020-10-10       Impact factor: 7.324

4.  Associations of Clinical Characteristics and Intestinal Flora Imbalance in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients and the Construction of an Early Warning Model.

Authors:  Xuetao Zeng; Hongfeng Yang; Yan Yang; Xinnan Gu; Xiuqin Ma; Taofeng Zhu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-18

Review 5.  COPD and Gut-Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics.

Authors:  Ling Qu; Qing Cheng; Yan Wang; Hui Mu; Yunfeng Zhang
Journal:  Front Microbiol       Date:  2022-04-01       Impact factor: 6.064

6.  Intestine-specific expression of human chimeric intestinal alkaline phosphatase attenuates Western diet-induced barrier dysfunction and glucose intolerance.

Authors:  Siddhartha S Ghosh; Hongliang He; Jing Wang; William Korzun; Paul J Yannie; Shobha Ghosh
Journal:  Physiol Rep       Date:  2018-07

7.  Walking exercise alters protein digestion, amino acid absorption, and whole body protein kinetics in older adults with and without COPD.

Authors:  Clayton L Cruthirds; Nicolaas E P Deutz; Gerdien C Ligthart-Melis; Sunday Y Simbo; Mariëlle P K J Engelen
Journal:  J Appl Physiol (1985)       Date:  2020-11-19

Review 8.  Gut Microbiota, in the Halfway between Nutrition and Lung Function.

Authors:  Christophe Espírito Santo; Catarina Caseiro; Maria João Martins; Rosário Monteiro; Inês Brandão
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

9.  Hypoxia and heat stress affect epithelial integrity in a Caco-2/HT-29 co-culture.

Authors:  Puqiao Lian; Saskia Braber; Soheil Varasteh; Harry J Wichers; Gert Folkerts
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

10.  Reduction in exacerbation of COPD in patients of advanced age using the Japanese Kampo medicine Dai-kenchu-to: a retrospective cohort study.

Authors:  Taisuke Jo; Nobuaki Michihata; Hayato Yamana; Yusuke Sasabuchi; Hiroki Matsui; Hirokazu Urushiyama; Akihisa Mitani; Yasuhiro Yamauchi; Kiyohide Fushimi; Takahide Nagase; Hideo Yasunaga
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.